Yale Dermatologists Identify Distinct Clinicopathologic Pattern for Kratom-Induced Hyperpigmentation

Why it matters

As kratom use rises nationwide, dermatologists now have clearer pathological criteria to identify kratom-induced skin discoloration — enabling earlier diagnosis and distinguishing it from other drug-related hyperpigmentation.

The big picture

Kratom use has been linked to photodistributed hyperpigmentation — patchy brown-gray discoloration in sun-exposed areas — since at least 2022, with scattered case reports in dermatology literature. Yale researchers build on prior cases to characterize the histopathologic signature, advancing it from anecdote to a recognizable clinical pattern. As millions of Americans use kratom, dermatologists increasingly need tools to recognize this side effect in clinical practice.

Key findings

• Two patients with chronic kratom use presented with symmetric brown-gray patches on the face, neck, and upper chest\nBiopsies showed circular orange-brown granules in the dermis, positive for melanin (Fontana-Masson stain) and negative for iron\nThe pattern is photodistributed, meaning it occurs in sun-exposed skin areas\nAuthors propose this constitutes a distinct clinicopathologic pattern identifiable by dermatopathologists\nThe cutaneous side effects of kratom have been incompletely characterized in medical literature until now

What they say

The authors write that their cases "suggest a possible distinct clinicopathologic pattern for which kratom use can be suspected" — providing dermatologists a histological fingerprint for this emerging drug-induced skin change.

Bottom line

Yale dermatologists have characterized a specific biopsy pattern for kratom-induced skin darkening, giving clinicians a reliable way to diagnose this increasingly common side effect.